Literature DB >> 9119506

Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice.

K Sinha1, P Mastroeni, J Harrison, R D de Hormaeche, C E Hormaeche.   

Abstract

Athymic (nu/nu) BALB/c mice and their euthymic (nu/+) littermates were inoculated intravenously with live attenuated vaccine strains of Salmonella typhimurium. All strains caused progressive infections in the athymic mice but not in their euthymic littermates. Athymic mice given strain SL3261, an aroA derivative of SL1344, in doses between log 4.7 and 5.7 CFU were all severely ill and were killed by weeks 4 to 5. Athymic mice given log 4.7 CFU of a derivative of S. typhimurium C5 carrying a mutation in htrA, encoding a stress protein, were ill and were killed by week 7 in one experiment but survived to week 13 in another. Athymic mice given log 4.6 CFU of a C5 aroD htrA double mutant were ill and were killed at week 7. Athymic mice given SL3261 had high bacterial counts in the reticuloendothelial system at 4 weeks. Athymic mice given SL3261 or C5 htrA made immunoglobulin G3 (IgG3) (and to a lesser extent IgM) antibody to lipopolysaccharide (LPS), whereas euthymic mice made IgM, IgG1, IgG2a, IgG2b, and IgG3 anti-LPS antibodies. The results indicate that both aroA and htrA strains will produce slow, progressively lethal infections in athymic mice, that the htrA strain is more attenuated than the aroA strain as measured by time to death in this model, and that IgG3 anti-LPS antibody alone cannot suppress the progress of infections by very attenuated strains in athymic mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119506      PMCID: PMC175172          DOI: 10.1128/iai.65.4.1566-1569.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The role of a stress-response protein in Salmonella typhimurium virulence.

Authors:  K Johnson; I Charles; G Dougan; D Pickard; P O'Gaora; G Costa; T Ali; I Miller; C Hormaeche
Journal:  Mol Microbiol       Date:  1991-02       Impact factor: 3.501

2.  Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium.

Authors:  C Nauciel; E Ronco; M Pla
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice.

Authors:  M Izhar; L DeSilva; H S Joysey; C E Hormaeche
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model.

Authors:  S N Chatfield; K Strahan; D Pickard; I G Charles; C E Hormaeche; G Dougan
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

5.  Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines for mice.

Authors:  K Strahan; S N Chatfield; J Tite; G Dougan; C E Hormaeche
Journal:  Microb Pathog       Date:  1992-04       Impact factor: 3.738

6.  Aromatic-dependent Salmonella as live vaccine presenters of foreign epitopes as inserts in flagellin.

Authors:  B A Stocker
Journal:  Res Microbiol       Date:  1990 Sep-Oct       Impact factor: 3.992

7.  Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies.

Authors:  P Mastroeni; A Arena; G B Costa; M C Liberto; L Bonina; C E Hormaeche
Journal:  Microb Pathog       Date:  1991-07       Impact factor: 3.738

8.  Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  The involvement of tumor necrosis factor in immunity to Salmonella infection.

Authors:  J P Tite; G Dougan; S N Chatfield
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

10.  Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Microb Pathog       Date:  1992-12       Impact factor: 3.738

View more
  40 in total

1.  Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection.

Authors:  James M Ertelt; Tanner M Johanns; Margaret A Mysz; Minelva R Nanton; Jared H Rowe; Marijo N Aguilera; Sing Sing Way
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 2.  Tracking the dynamics of T-cell activation in response to Salmonella infection.

Authors:  Rajesh Ravindran; Stephen J McSorley
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

3.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 4.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

5.  H2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.

Authors:  S Ugrinovic; C G Brooks; J Robson; B A Blacklaws; C E Hormaeche; J H Robinson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 6.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 7.  Animal Models for Salmonellosis: Applications in Vaccine Research.

Authors:  Ellen E Higginson; Raphael Simon; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

Review 8.  Genetic susceptibility to invasive Salmonella disease.

Authors:  James J Gilchrist; Calman A MacLennan; Adrian V S Hill
Journal:  Nat Rev Immunol       Date:  2015-07       Impact factor: 53.106

9.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  PIR-B-deficient mice are susceptible to Salmonella infection.

Authors:  Ikuko Torii; Satoshi Oka; Muneki Hotomi; William H Benjamin; Toshiyuki Takai; John F Kearney; David E Briles; Hiromi Kubagawa
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.